Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Immunology
Subjects:	glycoengineering antibody-dependent cellular cytotoxicity intravenous immunoglobulin autoimmune disease natural killer cell Fcγ receptor
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.902018/full

Similar Items

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
by: Yusuke Mimura, et al.
Published: (2022-01-01)

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
by: Cristina Capuano, et al.
Published: (2017-03-01)

Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
by: Christopher Beneduce, et al.
Published: (2023-08-01)

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
by: H.A. Daniel Lagassé, et al.
Published: (2021-06-01)

Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)

Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer
by: Bonnie J. B. Lewis, et al.
Published: (2019-12-01)

Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity
by: Alyson J. Smith, et al.
Published: (2023-11-01)

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS
by: Lidija Kareva
Published: (2016-12-01)

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
by: Gillian Dekkers, et al.
Published: (2017-08-01)

C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors in vitro
by: A. Robin Temming, et al.
Published: (2021-03-01)

Intravenous Immunoglobulin and its Complications
by: I Mohammadzadeh
Published: (2011-05-01)

Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
by: Gillian Dekkers, et al.
Published: (2018-03-01)

Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity
by: Frontiers Production Office
Published: (2023-12-01)

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
by: Yusuke Mimura, et al.
Published: (2017-06-01)

"High Doses Intravenous Immunoglobulin versus Oral Cyclosporine in the Treatment of Severe Atopic Dermatitis "
by: "Mohammad Hassan Bemanian, et al.
Published: (2005-09-01)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease
by: Elizabeth A. Fitzpatrick, et al.
Published: (2020-03-01)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
by: Bruce D. Wines, et al.
Published: (2021-10-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

Study on FcγRn Electrochemical Receptor Sensor and Its Kinetics
by: Dandan Peng, et al.
Published: (2020-07-01)

Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation
by: Philipp Kolb, et al.
Published: (2021-03-01)

Side Effects of Intravenous Immunoglobulin Treatment in Neurological Disorders
by: Buket Oflazoğlu, et al.
Published: (2006-02-01)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
by: Kate J. Dixon, et al.
Published: (2021-01-01)

EFFICACY OF INTRAVENOUS IMMUNOGLOBULINS IN COMPLEX TREATMENT OF PERINATAL INFECTIONS IN PRETERM NEONATES
by: V.A. Bushtyriev, et al.
Published: (2006-01-01)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
by: Patricia Gogesch, et al.
Published: (2021-08-01)

Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis
by: Nihar Shah, et al.
Published: (2014-01-01)

Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01)

Intravenous immunoglobulin: Revisited – My experience
by: Sanjeev S Vaishampayan, et al.
Published: (2021-01-01)

Peripheral CD56+CD16+ NK Cell Populations in the Early Follicular Phase Are Associated With Successful Clinical Outcomes of Intravenous Immunoglobulin Treatment in Women With Repeated Implantation Failure
by: Yao-Kai Ho, et al.
Published: (2020-01-01)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
by: Daniel A Rossignol, et al.
Published: (2021-05-01)

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
by: Angelina Konovalova, et al.
Published: (2023-10-01)

Stroke in a young adult receiving intravenous immunoglobulin therapy for immune thrombocytopenic purpura
by: Javed Iqbal Wani
Published: (2016-01-01)

Effectiveness of two same-manufacturer intravenous immunoglobulin for Kawasaki disease
by: Kun-Lang Wu, et al.
Published: (2024-04-01)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01)

LIVEdoid vasculopathy – benefit of intravenous immunoglobulin in a refractory case
by: Stefan Cristian Dinescu, et al.
Published: (2021-03-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
by: Stefanie Prohaska, et al.
Published: (2018-02-01)

Correlation of Anti-HLA IgA Alloantibodies and Fc Receptor Motives with Kidney Allograft Survival
by: Marie-Luise Arnold, et al.
Published: (2022-04-01)

Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor
by: Chunshu Yang, et al.
Published: (2019-12-01)

Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
by: Eun Jung Cheon, et al.
Published: (2024-01-01)